Jordi Rodón Ahnert, MD, PhD

Articles by Jordi Rodón Ahnert, MD, PhD

Jordi Rodón Ahnert, MD, PhDGastric Cancer | March 13, 2025
Dr. Rodón Ahnert compares the differences of sacituzumab tirumotecan use in the second- vs third-line setting for patients.
View More